Combination of Fresh Frozen Plasma and Cryosupernatant Plasma for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Institution Experience
Table 2
Components of PLASMIC and Bentley score of the enrolled patients.
Patient Number
FFP/CP ratio
Platelet count (×109/L)
Indirect bilirubin (μmol/L)
Uncorrected reticulocyte (%)
Active cancer
MCV (fL)
INR
Creatinine (μmol/L)
D-dimer (μg/ml)
PLASMIC score
Bentley score
1
0.61
8
22.7
21.63
NO
108.6
1.04
89
2.52
6
21
2
0.88
20
17.5
16.59
NO
101.1
1.05
62
2.1
6
21
3#
1.86
6
65.1
22.29
NO
108
1.02
68
3.12
6
41.5
4
0.73
29
16.7
18.72
NO
94.4
1.13
64.3
1.65
6
21
5
0.93
9
23.5
14.83
NO
86.2
1.2
84
1.18
7
21
6#
1.48
28
16.1
16.39
NO
109.3
1.01
67
2.13
6
21
7
0.85
6
28.1
19.74
NO
104
1.1
66
2.09
6
41.5
8
0.72
16
12.2
10
NO
95
1.04
39
0.65
6
21
9
1.14
12
80.4
16.73
NO
107.3
0.73
101
2.22
6
41.5
10
1.11
16
23.3
20.21
NO
99
0.99
62
0.8
6
21
11
0.94
11
82.3
4.84
Thyroid
71.7
1.18
178
6.21
5
20
12
1.40
18
18.6
9.76
NO
96.5
0.81
81
1.47
6
21
13
1.81
6
73
6.55
NO
84.1
0.98
86
1.84
7
41.5
14
0.56
6
49.7
19.32
NO
108.8
0.97
66.8
2.42
6
41.5
15
1.21
13
31.5
13.48
NO
100.6
0.98
68.4
3.76
6
41.5
16
0.73
21
17.5
4.83
NO
76.3
0.92
79
1.35
7
21
17
3.45
11
19.5
19.47
NO
86.4
0.72
108
2.97
7
21
18#
1.12
18
17
4.22
esophagus
88.3
0.86
67
0.99
6
21
19
1.08
11
62
4.71
NO
87.2
1.03
92
1.08
7
41.5
20
1.28
10
38.4
8.94
NO
102.2
1.11
52
0.66
6
41.5
21
1.25
13
16.7
16.8
NO
106
1.09
74
0.89
6
21
22
1.17
24
36.6
7.42
NO
89.4
1.17
95
3.61
7
41.5
23
1.28
21
12.3
11.32
NO
92.5
1.04
104
1.07
6
21
24
1.17
19
8.9
3.4
NO
85.2
0.92
40
0.5
7
21
25
0.87
11
43.3
17.22
NO
90.4
1.07
85.8
1.68
6
41.5
26
1.16
8
27.2
19.43
NO
90
1.09
60
8.22
6
31.5
27
0.89
22
8.3
9.42
NO
97.3
1.05
142
2.01
6
21
MCV: mean corpuscular volume; INR: international normalized ratio; : patients who were evaluated for ADAMTS13 activity; #: patients who did not achieve complete remission before therapeutic plasma exchange ceased.
